Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 3/20 | 0.34 |
| ▸ | RAB9A | P51151 | 3/20 | 0.34 |
| ▸ | AGTR1 | P30556 | 2/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | CES2 | O00748 | 1/20 | 0.30 |
| ▸ | CES1 | P23141 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1685488 | 1.00 | KDM4E (0.34) | KDM4EALOX15TSHRACMSDTDP1 | |
| SCHEMBL5889225 | 0.98 | NPC1 (0.33) | KDM4EALOX15TSHRACMSDTDP1 | |
| SCHEMBL5713531 | 0.98 | NPC1 (0.33) | KDM4EALOX15TSHRACMSDTDP1 | |
| Hydrochloric Acid SCHEMBL1685854 | 0.96 | NPC1 (0.35) | KDM4EALOX15TSHRACMSDTDP1 | |
| Hydrochloric Acid SCHEMBL1685853 | 0.96 | NPC1 (0.35) | KDM4EALOX15TSHRACMSDTDP1 | |
| SCHEMBL19347668 | 0.93 | NPC1 (0.31) | KDM4EALOX15TSHRACMSDTDP1 | |
| SCHEMBL5358692 | 0.92 | KDM4E (0.37) | KDM4EALOX15TSHRACMSDTDP1 | |
| SCHEMBL5358693 | 0.92 | KDM4E (0.37) | KDM4EALOX15TSHRACMSDTDP1 | |
| SCHEMBL2227999 | 0.90 | ACHE (0.36) | KDM4EALOX15TSHRACMSDTDP1 | |
| SCHEMBL2228003 | 0.90 | ACHE (0.36) | KDM4EALOX15TSHRACMSDTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2797862-B1 | OLEFIN OLIGOMERIZATION METHODS | CHEVRON PHILLIPS CHEMICAL CO LP (US) | 2021-04-07 | — | — | EP | disclosed |
| US-9586872-B2 | Olefin oligomerization methods | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2017-03-07 | — | — | US | disclosed |
| US-9586872-B2 | Olefin oligomerization methods | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2017-03-07 | — | — | US | disclosed |
| EP-2794691-A1 | PROCESS FOR CONTROLLING THE POLYMER COMPOSITION OF AN ETHYLENE COPOLYMER OBTAINED BY A CATALYST SYSTEM COMPRISING A TRANSITION METAL CATALYST COMPONENT AND A ZIEGLER CATALYST COMPONENT | Basell Polyolefine GmbH (DE) | 2014-10-29 | — | — | EP | disclosed |
| EP-2655445-A1 | PROCESS FOR CONTROLLING THE RELATIVE ACTIVITY OF ACTIVE CENTERS OF CATALYST SYSTEMS COMPRISING AT LEAST ONE LATE TRANSITION METAL CATALYST COMPONENT AND AT LEAST ONE ZIEGLER CATALYST COMPONENT | Basell Polyolefine GmbH (DE) | 2013-10-30 | — | — | EP | disclosed |
| WO-2013101387-A1 | OLEFIN OLIGOMERIZATION METHODS | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2013-07-04 | — | — | WO | disclosed |
| US-20130172651-A1 | Olefin Oligomerization Methods | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2013-07-04 | — | — | US | disclosed |
| US-20130172651-A1 | Olefin Oligomerization Methods | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2013-07-04 | — | — | US | disclosed |
| WO-2013092453-A1 | PROCESS FOR CONTROLLING THE POLYMER COMPOSITION OF AN ETHYLENE COPOLYMER OBTAINED BY A CATALYST SYSTEM COMPRISING A TRANSITION METAL CATALYST COMPONENT AND A ZIEGLER CATALYST COMPONENT | BASELL POLYOLEFINE GMBH (DE) | 2013-06-27 | — | — | WO | disclosed |
| WO-2012084774-A1 | PROCESS FOR CONTROLLING THE RELATIVE ACTIVITY OF ACTIVE CENTERS OF CATALYST SYSTEMS COMPRISING AT LEAST ONE LATE TRANSITION METAL CATALYST COMPONENT AND AT LEAST ONE ZIEGLER CATALYST COMPONENT | BASELL POLYOLEFINE GMBH (DE) | 2012-06-28 | — | — | WO | disclosed |
| WO-2007042252-A1 | HYBRID CATALYST SYSTEMS SUPPORTED ON MAGNESIUM HALIDE | BASELL POLYOLEFINE GMBH (DE) | 2007-04-19 | — | — | WO | disclosed |
| EP-1753791-A1 | POLYETHYLENE FOR INJECTION MOLDINGS | Basell Polyolefine GmbH (DE) | 2007-02-21 | — | — | EP | disclosed |
| EP-1753794-A1 | POLYETHYLENE AND CATALYST COMPOSITION FOR ITS PREPARATION | Basell Polyolefine GmbH (DE) | 2007-02-21 | — | — | EP | disclosed |
| EP-1542797-B1 | CATALYST SYSTEMS FOR ETHYLENE OLIGOMERISATION TO LINEAR ALPHA OLEFINS | SHELL INT RESEARCH (NL) | 2006-05-31 | — | — | EP | disclosed |
| US-7053020-B2 | Catalyst systems for ethylene oligomerisation to linear alpha olefins | SHELL OIL COMPANY (US) | 2006-05-30 | — | — | US | disclosed |
| US-7037988-B2 | Process for the co-oligomerisation of ethylene and alpha olefins | SHELL OIL COMPANY (US) | 2006-05-02 | — | — | US | disclosed |
| WO-2005103100-A1 | POLYETHYLENE AND CATALYST COMPOSITION FOR ITS PREPARATION | BASELL POLYOLEFINE GMBH (DE) | 2005-11-03 | — | — | WO | disclosed |
| WO-2005103096-A1 | POLYETHYLENE FOR INJECTION MOLDINGS | BASELL POLYOLEFINE GMBH (DE) | 2005-11-03 | — | — | WO | disclosed |
| US-20050014983-A1 | Process for producing linear alpha olefins | SHELL OIL COMPANY | 2005-01-20 | — | — | US | disclosed |
| US-20040116758-A1 | Catalyst systems for ethylene oligomerisation to linear alpha olefins | SHELL OIL COMPANY | 2004-06-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050014983-A1 | Process for producing linear alpha olefins | OXSR1, AP2S1, CBR3 | KDM4E 3055/4885ALOX15 201/4885TSHR 621/4885 |
| US-20130172651-A1 | Olefin Oligomerization Methods | COG4, OSTC, COG8 | KDM4E 4036/4885ALOX15 248/4885TSHR 3432/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.